RBT-1 reduces blood product utilization in patients undergoing nonemergency coronary artery bypass grafting and/or valve surgeryCentral Message by Charles A. Mack, MD, Michael Jessen, MD, Andre Lamy, MD, Ashish K. Khanna, MD, Kevin Lobdell, MD, Rakesh Arora, MD, Jeannette Rodriguez, PhD, Stacey Ruiz, PhD, Bhupinder Singh, MD

Get full text